Cutimed^® Sorbact Pad^®

is a bacteria and fungi binding wound dressing, based on Sorbact^® Technology. It consists of a Sorbact^® DACC™-coated wound contact layer combined with an absorbent core, which absorbs and retains exudate.

Prevents and treats wound infections
Safe removal of bacteria, fungi and endotoxins
Effective against most common resistant pathogens

Intended Purpose

Indications: Cutimed Sorbact Pad is intended for use in the management of clean, contaminated, colonised or infected moderate to high exuding wounds, such as surgical wounds, traumatic wounds, pressure ulcers, diabetic foot ulcers and leg ulcers. It is intended to be used on superficial wounds.

Wear time: Should the clinical condition allow, the dressing can be left in place for up to 7 days.

Learn about the product and how to apply it

Learn about the products' mode of action

Product benefits

Symbol of a shield representing infection prevention

Prevents and treats wound infections

Sorbact Technology dressings reduce bioburden and support effective wound healing, with no known contraindications and low risk of allergies^{1, 2, 3, 4, 5, 6}.

Symbol of looped threads to visualize that the product inhibits the growth of bacteria.

Safe removal of bacteria, fungi and endotoxins

Sorbact Technology dressings irreversibly bind and remove bacteria, without the release of active agents to the wound⁵. Development of bacterial or fungal resistance is not expected.

Effective against most common resistant pathogens

In vitro tests show that Sorbact Technology dressings are able to inhibit the growth of the Top 5 WHO pathogens⁷.

Symbol of a dressing being removed and a feather

Easy to use

A wound dressing that is easy to use and comfortable for the patient⁸.

Product facts

Superficial

Infected

Moderate to high

How to use

Image showing how to apply Cutimed® Sorbact® Dressing Pad

1. Prepare the wound and surrounding skin according to local clinical practice.
2. Select an appropriate dressing size for the wound. The wound pad should overlap the wound margins by at least 2 cm. Do not cut the dressing.
3. Remove the dressing from the peel pouch using an aseptic technique.
4. Apply the dressing. Ensure that the green contact layer comes into direct contact with the complete wound surface to allow microorganisms to bind to the dressing.
5. Fixate with bandage or skin friendly tape.
6. The dressing change frequency depends on exudate levels and the overall condition of the wound and surrounding skin. Should the clinical condition allow, the dressing can be left in place for up to 7 days.
How to Remove
Should the dressing adhere to the wound, moisten the dressing to assist removal and to avoid disruption of the healing wound.

Product specifications

PRODUCT	REF	Dimensions	Pieces/box	Pcs. definition	Pieces/shipper	Boxes/shipper	Sterile
Cutimed^® Sorbact Pad^®	7216123	7 cm x 9 cm	40	BOX OF 40 POUCHES OF 1	160	4	Yes
Cutimed^® Sorbact Pad^®	7216226	10 cm x 10 cm	40	BOX OF 40 POUCHES OF 1	80	2	Yes
Cutimed^® Sorbact Pad^®	7216314	10 cm x 20 cm	20	BOX OF 20 POUCHES OF 1	40	2	Yes

Medical References

¹ Bua N et al. Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017;44:387-392.

² Stanirowski P et al. Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing cesarean section. Surg Infect (Larchmt). 2016;17:427-435.

³ Kammerlander G et al. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. Wounds UK. 2008;4:10-18.

⁴ Mosti G et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24:121-122, 124-127.

⁵ Husmark J et al. Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study. J Wound Care. 2022;31:560-570.

⁶ Gentili V et al. Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed Sorbact. Eur J Clin Microbiol Infect Dis. 2012;31:1523-1529.

⁷ Husmark J et al. Antimicrobial effect of a DACC-coated bacteria-binding wound dressing against WHO pathogens. EWMA. November 18-19, 2020, virtual conference (EP006).

⁸ Haycocks S et al. Use of a DACC-coated antimicrobial dressing in people with diabetes and a history of foot ulceration. Wounds UK. 2011;7:108-114.